Aging and Disease, 2024 · DOI: http://dx.doi.org/10.14336/AD.2023.0509 · Published: February 1, 2024
Spinal cord injury (SCI) can lead to persistent neurological deficits. Excessive iron deposition and immune cell infiltration contribute to the pathological features of SCI. The study identifies Cathepsin B (CTSB) as a key gene involved in cellular ferroptosis following SCI. Inhibiting CTSB with a small-molecule drug, CA-074-methyl ester (CA-074-me), reduced lipid peroxidation and mitochondrial dysfunction in macrophages. M2-polarized macrophages are more susceptible to hemin-induced ferroptosis. CA-074-me could reduce ferroptosis, induce M2 macrophage polarization, and promote the neurological function recovery of mice after SCI. The study provides a novel molecular target for SCI treatment.
CTSB is identified as a novel molecular target for SCI treatment, providing a potential avenue for developing new therapies.
Promoting M2 macrophage polarization through CTSB inhibition can enhance tissue repair and neurological function recovery after SCI.
CA-074-me shows promise as a therapeutic agent for reducing ferroptosis and improving outcomes in SCI, warranting further investigation and potential clinical trials.